Past event: Risk Evaluation & Mitigation Strategies Summit

Elevate Risk Management Operations to Ensure Patient-Centricity, Open Communication Channels, and Advanced Efficacy

We are proud to announce the 10th anniversary of the Risk Evaluation & Mitigation Strategies Summit. This event continues to attract the most elite professionals, hailing from branded and generic pharmaceutical and biotech companies with responsibilities in risk management. Over the past decade, REMS professionals have depended on this summit for comprehensive elucidation in achieving compliance and innovation in an evolving healthcare landscape.

We welcome you to witness firsthand why our event remains the conference of choice for REMS professionals. Our star-studded speaking faculty will arm you with the proven strategies to facilitate benefit-risk counseling, optimize REMS through health system integration, leverage technological advances and accomplish much more! The 10th REMS Summit provides you with the tools and methods to evaluate and improve a compliant REMS program, in order to improve patient safety and outcomes.


Top Five Reasons to Attend

  1. Fashion nimble structures for prompt risk identification and timely responses
  2. Evaluate your REMS program to determine the necessary methods to ensure compliance
  3. Assess patient safety and outcomes to refine REMS accordingly
  4. Determine solutions to integrate REMS with healthcare systems and pharmacies
  5. Promote patient outcomes by leveraging technological advances

Speakers

  • Jason Ancell, Program Manager, INVENTIV HEALTH CONSULTING
  • Stacy Cooper Bailey, Ph.D., MPH, Assistant Professor, Division of Pharmaceutical Outcomes and Policy, UNC ESHELMAN SCHOOL OF PHARMACY
  • Kim H. Bullano, B.S., Pharm.D., Senior Director, Risk Management Team Lead, SHIRE
  • May Chan-Liston, Director, REMS Strategy and Policy, CELGENE CORPORATION
  • Pat daCosta, Pharm.D., REMS Sr. Product Manager, RELAYHEALTH
  • Ruth S. Day, Ph.D., Director, Medical Cognition Lab, Senior Fellow, Center for Aging and Human Development, DUKE UNIVERSITY
  • Michael von Forstner, Co-Chair, Pharmacovigilance Working Group, MEDICINES FOR EUROPE
  • Emily Freeman, Ph.D., Director, Risk Management Sciences, ABBVIE
  • Kevin Holman, Senior Director, Drug Regulatory Affairs, ACTELION
  • Cynthia Kear, Lead, Collaboration Management, CO*RE
  • John Klimek, R.Ph., SVP Standards and IT, NATIONAL COUNCIL FOR PRESCRIPTION DRUG PROGRAMS, INC
  • Nathan Kopper, Pharm.D, Director, REMS Consulting and Strategy, MCKESSON
  • Dean T. Parry, RPH, Assistant Vice President, Clinical Informatics, Care Support Services, GEISINGER HEALTH SYSTEM
  • Larry Risen, MBA, President and CEO, BIOTRAK RESEARCH
  • Suzanne Robottom, Pharm.D., Regulatory Health Policy Analyst, Division of Risk Management, Office of Medication Error Prevention and Risk Management, Office of Surveillance and Epidemiology, FDA
  • Adam E. Saltman, M.D., Ph.D., FACS, FACC, FACP, FAHA, Medical Officer, CDRH Office of Compliance, FOOD AND DRUG ADMINISTRATION
  • Linda Scarazzini, M.D., Vice President, Pharmacovigilance and Patient Safety (PPS), ABBVIE
  • Paul Sheehan, Executive Director, Head of U.S. REMS, CELGENE CORPORATION
  • Gary Slatko, M.D., M.B.A, Associate Office Director, Medication Error Prevention and Risk Management, CDER, FOOD AND DRUG ADMINISTRATION
  • Rachel Sobel, Senior Director, Epidemiology - Group Lead Global Innovative Pharma, PFIZER
  • Annette Stemhagen, MPH, DrPH, Senior Vice President, Safety, Epidemiology, Registries and Risk Management, UNITED BIOSOURCE CORPORATION
  • Deborah Tiffany, Director, Global Risk Management Product Lead, Process Analyst, Worldwide Safety and Regulatory, PFIZER
  • Gita Toyserkani, Pharm.D., MBA, Regulatory Health Policy Analyst, Division of Risk Management, Office of Medication Error Prevention and Risk Management, Office of Surveillance and Epidemiology, FDA
  • Andrew Wasson, Partner, HAUG
  • Scott Wirth, Pharm.D., BCOP, Clinical Assistant Professor, Department of Pharmacy Practice Clinical Pharmacist, Oncology, UNIVERSITY OF ILLINOIS AT CHICAGO COLLEGE OF PHARMACY
  • Michael Wolf, Ph.D., MPH, Professor, Medicine and Learning Sciences, Associate Chair, Department of Medicine, Associate Division Chief, Research, General Internal Medicine and Geriatrics, FEINBERG SCHOOL OF MEDICINE, NORTHWESTERN UNIVERSITY

Please fill in your name and email to receive the conference agenda of this event.

Conference Day One - Monday, January 29, 2018

Conference Day Two - Tuesday, January 30, 2018

The agenda is available as PDF under downloads at the right side of the page.

Venue

The venue is not yet available for this event.
Follow this event to be informed when the venue is available and stay informed on other changes.

Who Should Attend

This event is ideal for professionals from payers and pharmaceutical, biotechnology and medical device companies with responsibilities in the following areas:
  • REMS
  • Risk Management
  • Pharmacovigilance/Surveillance
  • Quality Assurance
  • Drug/Product Safety
  • Clinical Risk Management
  • Life Cycle Management
  • Regulatory Affairs/Legal/Compliance
  • Clinical Affairs
  • Clinical Data Management
  • Clinical Operations
  • Clinical Risk Management Compliance
  • Epidemiology/Pharmacoepidemiology
  • Marketing

This conference is also of interest to:
  • Risk Safety and REMS Service Providers
  • Data Management Service Providers
  • Healthcare Information Marketing and Technology Providers
  • Dashboard and Metrics Service Providers
  • Law Firms
  • Consultancies


Venue

Hilton Crystal City at Reagan National Airport
2399 Jefferson Davis Hwy
Arlington, VA 22202

Soak up the historical ambiance of our nation’s capital from the Hilton Crystal City at Washington Reagan National Airport hotel. Located next to the Reagan National Airport in Arlington, VA, we offer easy access to the Washington, DC Metrorail, putting you just steps away from national monuments, museums, government agencies, shops and restaurants. Enjoy a delicious meal at one of our on-site dining options and stay connected with complimentary WiFi throughout the hotel.

To make reservations, please call 1-800-695-7551 and request the negotiated rate for ExL’s January Meetings. To make reservations online Click Here

The group rate is available until January 9, 2018. Please book your room early, as rooms available at this rate are limited.
Event details
Organizer : ExL
Event type : Conference
Reference : ASDE-17410